Drug Shortage Report for DEPO-MEDROL

Last updated on 2022-09-01

Report ID 153221
Drug Identification Number 00030759
Brand name DEPO-MEDROL 40 MG/ML
Common or Proper name DEPO-MEDROL 40 MG/ML
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHYLPREDNISOLONE ACETATE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Packaging size 10 x 1mL vial
Anatomical Therapeutical Chemical (ATC) code H02AB
Anatomical Therapeutical Chemical (ATC) description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-20
Estimated end date
Actual end date 2022-08-31
Shortage status Resolved
Updated date 2022-09-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2022-09-01 French Compare
v11 2022-09-01 English Compare
v10 2022-06-27 French Compare
v9 2022-06-27 English Compare
v8 2022-05-19 French Compare
v7 2022-05-19 English Compare
v6 2022-02-24 English Compare
v5 2022-01-21 English Compare
v4 2022-01-20 French Compare
v3 2022-01-20 English Compare
v2 2022-01-20 French Compare
v1 2022-01-20 English Compare

Showing 1 to 12 of 12